XinNuoMing Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $5.49M

  • Investors
  • 1

XinNuoMing Bio General Information

Description

Developer of viral vaccines and monoclonal antibody products for medical use. The company is committed to the research and development of viral vaccines, bacterial vaccines and antibody biological products. Its business covers small-scale and pilot process development, cell bank preparation, bacterial and toxin strain preparation, cell culture, fermentation, preliminary and fine purification, packaging and freeze-drying.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Chengdu Shuangliu District Tianfu International Bio-city D3
  • Chengdu, Sichuan 610000
  • China
+86 133
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Chengdu Shuangliu District Tianfu International Bio-city D3
  • Chengdu, Sichuan 610000
  • China
+86 133

XinNuoMing Bio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XinNuoMing Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 17-Oct-2025 $5.49M Completed Generating Revenue
2. Early Stage VC 21-Jul-2023 Completed Generating Revenue
1. Early Stage VC 19-Jan-2023 Completed Generating Revenue
To view XinNuoMing Bio’s complete valuation and funding history, request access »

XinNuoMing Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chengdu Olymvax Corporation Minority
To view XinNuoMing Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

XinNuoMing Bio FAQs

  • When was XinNuoMing Bio founded?

    XinNuoMing Bio was founded in 2021.

  • Where is XinNuoMing Bio headquartered?

    XinNuoMing Bio is headquartered in Chengdu, China.

  • What industry is XinNuoMing Bio in?

    XinNuoMing Bio’s primary industry is Drug Delivery.

  • Is XinNuoMing Bio a private or public company?

    XinNuoMing Bio is a Private company.

  • What is the current valuation of XinNuoMing Bio?

    The current valuation of XinNuoMing Bio is .

  • What is XinNuoMing Bio’s current revenue?

    The current revenue for XinNuoMing Bio is .

  • Who are XinNuoMing Bio’s investors?

    Chengdu Olymvax has invested in XinNuoMing Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process